MBOAT7 and metabolic dysfunction-associated steatotic liver disease: Hepatocytes with reduced MBOAT7 expression have increased proliferation and migration [170], which may explain the association of reduced MBOAT7 expression, such as with the rs641738 TT MBOAT7 genotype, with an increased risk of hepatocellular carcinoma in NAFLD patients without cirrhosis [171].